Article Figures & Data
Figures
- Fig 1.
Anteroposterior oblique views, selective right ICA injection.
A, Right PCOM aneurysm in association with fetal-type PCA after the insertion of six coils. Image shows minor projection of coils into the terminal ICA (arrow), which demonstrates spasm. Contrast material irregularly fills the proximal ACA, with nonvisualization of the distal ACA. These findings are consistent with thrombus (arrowhead).
B, Immediately after the intravenous injection of abciximab 20 mg, the A1 segment of the ACA (arrowhead) is completely recanalized. Minor filling defect in the proximal A2 (arrow) dissipated shortly afterward.
- Fig 2.
Anteroposterior views.
A and B, Selective right ICA injection after the insertion of three coils. Before abciximab treatment (A), thrombus is seen at the neck of the aneurysm (arrowhead) and in the proximal right A2 segment of the right anterior cerebral artery (arrow). After abciximab (B), improvement in both is noted.
C and D, Selective injection after the insertion of five coils and aneurysm rupture. In C, thrombus (arrow) is present in the distal A1 segment and ACOM, with adjacent extravasation of contrast material (arrowhead). After heparin reversal, repeat angiogram in D demonstrates aneurysm occlusion, cessation of extravasation, and absence of thrombus, but marked vasospasm is present.
Tables
Patient Demographic Data
Age (years)/Sex Site Size (mm) WFNS Grade at Presentation Proximal/Distal Thrombosis Aneurysm Occluded/(%)/No of Coils before Cx/Further Coils Abciximab Dose/Route Angiographic Response Deficit or Complication/GOS GOS 56/F ACOM 5.7 × 3.5 1 P No (80%)/3/2 5mg Abciximab IV, 500mg aspirin IV Complete, immediate Rupture 6 68/M ACOM 5 × 3 1 P Yes/5/0 5mg Abciximab IV, 30mg Papavarine IA Complete, immediate None 1 27/F PCOM 98 × 8 1 P Yes/5/0 5mg Abciximab IV Partial, immediate None 1 63/M ACOM 6.5 × 7.5 2 P Yes/4/0 20mg of Abciximab IV,500mg aspirin IV Partial,immediate Shunt/haematomaevacuation 4 72/F PCOM 2.2 × 3 × 2 2 D No (0%)/0/4 5mg Abciximab x2 IV,direct agitation ofbasilar thrombus Partial,immediate Cerebellarinfarct 1 52/M ACOM 7 × 5 1 P No (60%)/4/0 5mg Abciximab IV ×2,500mg aspirin IV Complete,immediate None 1 59/M Basilar tip 12 × 12 × 10 5 D No (20%)/6/0 10mg Abciximab IV Complete,immediate PCA infarct 1 79/F ACOM 7 × 5.4 × 6.7 1 D Yes/4/0 7.5mg Abciximab IV Complete,immediate RightACAinfarct 1 51/F PCOM 6.3 × 6 × 7 5 to 2 P, D Yes/13/0 Abciximab 5mg IV Complete,immediate None 1 70/M MCA 5 × 4 2 D Yes/4/0 5mg Abciximab IV,40mg Papavarine IA,5mg Abciximab IV,30mg Papavarine IA Partial aftersecondAbciximabdose Transienthemiparesis 1 52/F PCOM 15 × 14 1 P No (90%)/13/3 500mg aspirin IV,Abciximab 5mg IV Complete,immediate Transienthemiparesis/dysphasia 1 46/F PICA 2 × 5 × 2 1 P Yes/2/0 Abciximab 5mg IV/500 mg aspirin IV NA/prophylaxis None 1 29/F PCOM 9 × 7.6 2 P Yes/6/0 Abciximab 5mg IV Complete,immediate Transient lefthemiparesis 1
In this issue
Jump to section
Related Articles
Cited By...
- Intra-arterial versus intravenous abciximab therapy for thromboembolic complications of neuroendovascular procedures: case review and meta-analysis
- Rescue Treatment of Thromboembolic Complications during Endovascular Treatment of Cerebral Aneurysms: A Meta-Analysis
- Rescue Treatment of Thromboembolic Complications During Endovascular Treatment of Cerebral Aneurysms
- Adjunctive use of eptifibatide for complication management during elective neuroendovascular procedures
- Intra-arterial abciximab for the treatment of thrombus formation during coil embolization of intracranial aneurysms
- Clinical and Angiographic Follow-up of Ruptured Intracranial Aneurysms Treated with Endovascular Embolization
- Abciximab Is a Safe Rescue Therapy in Thromboembolic Events Complicating Cerebral Aneurysm Coil Embolization: Single Center Experience in 42 Cases and Review of the Literature